The global minimally invasive surgery market size is calculated at US$ 81.69 billion in 2024, grew to US$ 94.8 billion in 2025, and is projected to reach around US$ 362.43 billion by 2034. The market is expanding at a CAGR of 16.05% between 2025 and 2034.
Increasing demand for MIS: There is a rise in the demand for MIS due to its less pain, scarring, and faster recovery. This, in turn, is increasing their adoption as well as advancements to enhance their applications. Therefore, the collaborations among the companies and investments are increasing to accelerate these innovations.
For instance,
The development of advanced technologies and techniques, such as improved imaging, AI, and robotics, to enhance the surgical precision and minimize the recovery time, is the main focus in the R&D of minimally invasive surgery.
Key Players: Medtronic plc, Intuitive Surgical Inc., Stryker Corporation, Johnson & Johnson, Boston Scientific Corporation, Zimmer Biomet Holdings, Inc., Olympus Corporation.
The clinical trials and regulatory approval of the minimally invasive surgery involve the evaluation of their effectiveness and safety for their intended use.
Key Players: Medtronic plc, Intuitive Surgical Inc., Johnson & Johnson, Boston Scientific Corporation.
The distribution to the hospitals and pharmacies of minimally invasive surgery includes the supply of specialized surgical devices, equipment, and associated medications by a multi-tiered supply chain.
Key Players: Medtronic plc, Intuitive Surgical Inc., Stryker Corporation, Johnson & Johnson.
To enhance the recovery and patient satisfaction, the patient support and services focus on providing patient-centred counselling, pre-operative education, and post-operative care.
Key Players: Medtronic plc, Intuitive Surgical Inc., Practo, Doctors App, HealthPlix, CipherHealth.
In September 2025, the Consultant Cardiothoracic Surgeon, Dr. Mallampati Sameer, at Renova Century Hospitals, stated that, as there is a growth in the Transcatheter Aortic Valve Replacement (TAVR) and other catheter-based interventions, and with the growing patients' demand for minimally invasive options with quicker recovery, there is a need to evolve the surgeries. Thus, they are moving forward with these innovations with the launch of Minimally Invasive Cardiac Surgery (MICS).
Become a valued research partner with us, please feel free to contact us at sales@towardshealthcare.com